XML 33 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenues:    
Product sales $ 656,071 $ 18,830
Other revenue 40,719 4,320
Total revenues 696,790 23,150
Cost of revenues 420,016 18,611
Gross profit 276,774 4,539
Operating Expenses:    
Selling, general and administrative 6,653,465 2,607,397
Research and development 2,236,985 734,776
Total expenses 8,890,450 3,342,173
Loss from operations (8,613,676) (3,337,634)
Other Income (Expense):    
Interest income 291,494 2,912
Interest expense 0 (1,304)
Other (3,306) (409)
Other income (expense) 288,188 1,199
Net loss $ (8,325,488) $ (3,336,435)
Net loss per basic and diluted common share $ (0.29) $ (0.14)
Weighted average common shares used to compute net loss per basic and diluted common share 28,652,625 23,578,291